WaveMan · Form 4
Schneeberger Daniel insider trades
> Search tickers & screens ⌘K
LIVE

Schneeberger Daniel insider trades

Schneeberger Daniel has filed 5 Form 4s with the SEC that we hold, for Keros Therapeutics, Inc. (KROS) (10% owner), Rallybio Corp (RLYB) (10% owner) and InMed Pharmaceuticals Inc. (INM) (10% owner). Across all of them we count 10 purchases worth $4.0M and 3 sales worth $95.7M reported on Form 4. In the last 12 months: 10 purchases ($4.0M) and 3 sales ($95.7M). The largest single trade was a sale of 4,391,237 shares of Keros Therapeutics, Inc. worth $77.9M, dated 2025-10-15. The first filing on our record is dated 2025-06-24 and the latest 2026-05-21.

Keros Therapeutics, Inc. (KROS)

10% owner · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-15S, sale reported on Form 4254,669$4.5M2025-10-15
2025-10-15S, sale reported on Form 44,391,237$77.9M2025-10-15
2025-10-15S, sale reported on Form 4743,358$13.2M2025-10-15

Rallybio Corp (RLYB)

10% owner · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-05-04P, purchase reported on Form 43,900$54.2K2026-05-06
2026-05-04P, purchase reported on Form 4116,904$1.6M2026-05-06
2026-05-05P, purchase reported on Form 435,101$491.4K2026-05-06
2026-05-13P, purchase reported on Form 44,081$56.3K2026-05-15
2026-05-13P, purchase reported on Form 475,178$1.1M2026-05-15
2026-05-15P, purchase reported on Form 4200$2.8K2026-05-15
2026-05-15P, purchase reported on Form 4100$1.4K2026-05-15

InMed Pharmaceuticals Inc. (INM)

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-05-19P, purchase reported on Form 468,551$109.7K2026-05-21
2026-05-19P, purchase reported on Form 4200,000$312.0K2026-05-21
2026-05-19P, purchase reported on Form 4200,000$300.0K2026-05-21
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1861120) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms